Pharmacodynamic evaluation of hypoglycemic effect of Damtab in healthyadult male volunteers > Volume 07 - 2007

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

Oriental Pharmacy and Experimental Medicine
Volume 07 - 2007
Date: 2007

Journal: Pages 205-210

June 2007 | Pharmacodynamic evaluation of hypoglycemic effect of Damtab in healthyadult male volunteers…

Pratap Kumar Sahu1, AK Najmi2,*, KK Pillai2, Nilanjan Saha3 and Manju Sharma2

첨부파일

Summary

​The objectives of the study were (1) To evaluate the safety and tolerability of Damtab. (2) Tocharacterize hypoglycemic effect of Damtab, if any. (3) To evaluate insulin sensitivity effect ofDamtab, if any. Hypoglycemic effect of Damtab (700 mg and 1,400 mg) were examined. Gliclazide(80 mg) was used as an active control. Placebo was used as control. Breakfast was given, half anhour before dosing whereas lunch, snacks and dinner were given at 6, 10 and 14 h post dose. Anoral glucose tolerance test was conducted to calculate the insulin sensitivity index from the valuesof glucose and insulin during oral glucose tolerance test. Both giclazide 80 mg and Damtab 1,400mg significantly lowered plasma glucose level up to 6 h. Insulin sensitivity index of Damtab(1,400 mg) was found to be similar to that of placebo. A significant increase in insulin level at 1 hpost dose of Damtab (1,400 mg) was observed. Damtab 700 mg shows placebo like effect whereasDamtab 1,400 mg possesses hypoglycemic effect.


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View